Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Acino Pharma (Pty) Ltd

02 9Biogen

03 1Sandoz B2B

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

NATALIZUMAB

Brand Name : TYSABRI

Dosage Form : VIAL; SINGLE-USE

Dosage Strength : 300MG

Packaging :

Approval Date :

Application Number : 125104

Regulatory Info :

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

natalizumab

Brand Name : Tysabri

Dosage Form : CONCENTRATE FOR SOLUTION FOR INFUSION

Dosage Strength : 300 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Natalizumabum

Brand Name : Tysabri

Dosage Form : Inf Conc

Dosage Strength : 300mg/15ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Natalizumabum

Brand Name : Tysabri

Dosage Form : Inj L?s

Dosage Strength : 150mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

NATALIZUMAB

Brand Name : TYSABRI

Dosage Form : SOLUTION

Dosage Strength : 300MG/15ML

Packaging : 1VIAL

Approval Date :

Application Number : 2286386

Regulatory Info : Prescription

Registration Country : Canada

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

natalizumab

Brand Name : Tysabri

Dosage Form :

Dosage Strength :

Packaging : 2

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

natalizumab

Brand Name : Tysabri

Dosage Form :

Dosage Strength :

Packaging : 2

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

natalizumab

Brand Name : Tysabri

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

natalizumab

Brand Name : Tysabri

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

NATALIZUMAB-SZTN

Brand Name : TYRUKO

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 300MG/15ML(20MG/ML)

Packaging :

Approval Date :

Application Number : 761322

Regulatory Info :

Registration Country : USA

blank

11

Acino Pharma (Pty) Ltd

Country
2024 ACI Convention
Not Confirmed
arrow

Acino Pharma (Pty) Ltd

Country
arrow
2024 ACI Convention
Not Confirmed

Natalizumab

Brand Name : Tysabri

Dosage Form : INF

Dosage Strength : 20mg/ml

Packaging : 15X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank